Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group
| Image |  |
|---|---|
| Description | scientific article published on 17 February 2017 |
| Author/s |
author: Carmen Guillen Ponce Roberto Antonio Pazo-Cid Antonia Salud |
| Publication date | February 17, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |